Home › Hidradenitis Suppurativa › Pennsylvania
Hidradenitis Suppurativa clinical trials in Pennsylvania
6 studies for Hidradenitis Suppurativa are looking for participants at sites in Pennsylvania.
Cities in Pennsylvania
Pharmacokinetics, Safety, and Efficacy of Povorcitinib in Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa
- Geisinger Medical Center, Danville
RecruitingPhase 2
Ages 12 to 17 · All sexes · Updated Nov 13, 2026 · NCT07213973Rollover Study for Participants Previously Enrolled in Clinical Trials of Povorcitinib
- Investigative Site US138, Danville
- Investigative Site US074, Philadelphia
- Investigative Site US069, Plymouth Meeting
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Nov 13, 2026 · NCT06855498An Extension Study to Assess Safety and Efficacy of Remibrutinib in Participants With Moderate to Severe HS
- UP Medical Center H System, Pittsburgh
RecruitingPhase 3
Ages 18 to 100 · All sexes · Updated Nov 9, 2026 · NCT07665437Safety and Efficacy of Soquelitinib in Adults With Hidradenitis Suppurativa
- Clinical Site 6, Camp Hill
- Clinical Site 8, Philadelphia
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Oct 15, 2026 · NCT07828860Myriad™ Augmented Soft Tissue Reconstruction Registry
- Lancaster General Hospital, Lancaster
RecruitingObservational study
Ages 18 and older · All sexes · Updated Jul 15, 2026 · NCT05243966Radiotherapy for Refractory Hidradenitis Suppurativa
- Thomas Jefferson University, Philadelphia
Recruiting
Ages 18 and older · All sexes · Updated May 15, 2026 · NCT07414550From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.